When the BoE first mooted active gilt sales back in May 2022, gilts yielded less than 2 per cent. Active QT made perfect ...

Higher valuations of the biggest seven companies . . . Higher political stability, stronger economic growth, and better ...

A ghoulish past clings like mist to the Scottish capital — if its walls could speak, they’d be screaming . . .

Billionaire Paul Coulson is ceding control of packaging group to bondholders but some noteholders are unhappy over terms ...

Former French president is expected to appeal his conviction for criminal conspiracy as he enters La Santé jail ...

Donald Trump’s announcement that his next summit with Vladimir Putin will be hosted by the pro-Russian prime minister of ...

The Dutch government is preparing to send tens of migrants to Uganda under a deal similar to one struck by the Trump ...

Maccabi Tel Aviv has said it would reject any tickets for its Europa League football match in Birmingham next month, despite ...

Breakthroughs in RNA editing and radioligand therapies are poised to take biotech into a new era – driving innovation, growth and new investment opportunities Biotechnology is entering a dynamic new ...

Rachel Reeves is to unveil a “blitz on business bureaucracy” in a renewed push to cut red tape that she claims will save ...

Trump surrounds him with stones on the Go board and says: “That’s a shame. I’ll have to give [Volodymyr] Zelenskyy permission ...

Interesting article by Tim Harford ( Spectrum, October 11) about the price of H-1B visas — particularly regarding the late ...